Проф. д.м.н. Adnan Kaya

Образование и специализация

• 2020–2021 — Клиника Memorial Bahçelievler — стипендиальная программа CHIP (Complex High-Risk Indicated Procedures)

• 2016–2020 — Медицинский факультет Университета Дюздже — ассистент-профессор и доцент

• 2010–2014 — Больница торакальной и сердечно-сосудистой хирургии им. д-ра Сиями Эрсека — ординатура по кардиологии

• 2002–2009 — Медицинский факультет Университета Хаджеттепе — медицинское образование

Профессиональный опыт

• 2020–2021 — Клиника Memorial Bahçelievler — кардиолог-феллоу по сложным коронарным вмешательствам и хроническим тотальным окклюзиям

• 2016–2020 — Университетская больница Медицинского факультета Университета Дюздже — кардиолог

• 2014–2016 — Государственная больница Суруч — кардиолог

• 2010–2014 — Больница торакальной и сердечно-сосудистой хирургии им. д-ра Сиями Эрсека — ординатор по кардиологии

Награды

• FESC — стипендиат Европейского общества кардиологов

• FSCAI — стипендиат Общества сердечно-сосудистой ангиографии и интервенций

Профессиональные членства

• Турецкое общество кардиологии

• Турецкая медицинская ассоциация

• Европейское общество кардиологии

• Kaya A, Tatlisu MA, Kaplan Kaya T, Yildirimturk O, Gungor B, Karatas B, Yazici S, Keskin M, Avsar S, Murat A. Sublingual vs. Oral Captopril in Hypertensive Crisis. Journal of Emergency Medicine. 2016;50(1):108–115.

• Alper AT, Kaya A, Tekkesin Aİ, Öz A. Authors’ reply. Turkish Journal of Cardiology Archives. 2016;44(5):451–453.

• Kaya A, Caliskan E, Oz A, Keskin M. Penetrating gunshot injury. Northern Clinics of Istanbul. 2015;2(2):151.

• Kaya A, Keskin M, Tatlisu MA, Kayapinar O. More about the effect of dynamic potassium change in STEMI. Angiology. 2019;70(1):89–90.

• Çinar T, Keskin M, Kaya A. Atrial fibrillation: A new risk factor for contrast-induced nephropathy. Angiology. 2019;70(5):470.

• Kaya A, Keskin M, Tatlisu MA, Uzman O, Borklu E, Cinier G, Yildirim E, Kayapinar O. Atrial fibrillation: A novel risk factor for no-reflow following primary percutaneous coronary intervention. Angiology. 2020;71(2):175–182.

• Özde C, Kaya A, Akbudak IH, Aktüre G, Kayapinar O. Acute effects of Red Bull energy drinks on atrial electromechanical function in healthy young adults. American Journal of Cardiology. 2020;125(4):570–574.

• Kaya A. Author’s reply. Anatolian Journal of Cardiology. 2017;17(3):250–251.

• Kayapinar O, Kaya A, Ozde C, Cebeci D, Unlu I. Evaluating the effect of nasal septoplasty on atrial electromechanical features. American Journal of Otolaryngology. 2019;40(2):179–182.

• Kaya A, Tatlısu MA, Tekkesin Aİ, Alper AT. CRT-D or CRT-P in CRT-indicated patients? Anatolian Journal of Cardiology. 2017;17(1):79–80.

• Kaya A, Kayapınar O. Discovering an overlooked fact in atrial fibrillation: Iron deficiency. Turkish Journal of Cardiology Archives. 2018;46(4):332.

• Kaya A, Keskin M, Tatlisu MA, Cinar T. Association of SYNTAX score with abdominal aortic intima-media thickness in non-ST elevation myocardial infarction. Angiology. 2019;70(6):569–570.

• Kacmaz F, Kaya A, Keskin M, Keceoglu S, Algin IH, Yilmazkaya B, Ilkay E. Clinical outcomes of extended endovascular recanalization of Buerger’s disease patients. Vascular. 2019;27(3):233–241.

• Keskin M, Kaya A, Cinar T, Hayiroglu Mİ, Orhan AL. Essential risk factors for contrast-induced nephropathy in STEMI. Angiology. 2019;70(7):674.

• Hayıroğlu Mİ, Keskin M, Uzun AO, Yıldırım Dİ, Kaya A, et al. Predictors of in-hospital mortality in acute coronary syndromes. Heart, Lung and Circulation. 2019;28(2):237–244.

• Kaya A, Keskin M, Güvenç TS, Tatlısu MA, Kayapınar O. Predictive role of modified TIMI risk index in STEMI. Acta Cardiologica. 2019;74(1):29–36.

• Kaya A, Keskin M, Tatlisu MA, Kayapinar O. Effect of dynamic potassium change on mortality in STEMI. Angiology. 2019;70(1):69–77.

• Akbaş-Şimşek T, Onat A, Kaya A, et al. Sex-dependent prediction of diabetes by depressive symptoms. International Journal of Geriatric Psychiatry. 2017;32(12):1425–1432.

• Keskin M, Uzun AO, Hayıroğlu Mİ, Kaya A, et al. Right ventricular dysfunction and outcomes in anterior myocardial infarction. International Journal of Cardiovascular Imaging. 2019;35(1):77–85.

• Kayapinar O, Kaya A, Keskin M, Tatlisu MA. Antithrombotic therapy in new-onset atrial fibrillation after STEMI. American Journal of Therapeutics. 2021;28(1):e30–e40.

• Altay S, Onat A, Kaya A, Tusun E. Modulators of J-shaped association of HbA1c with mortality. Cardiology. 2016;135(1):50–51.

• Tekkeşin Aİ, Velibey Y, Türkkan C, et al. ECG predictors of asymptomatic atrial fibrillation. Balkan Medical Journal. 2017;34(5):417–424.

• Kaya A, Hayıroğlu Mİ, Keskin M, Öz A, Aydın BA. Giant biventricular thrombi presenting with acute myocardial infarction. Indian Heart Journal. 2016;68(Suppl 2):S153–S155.

• Avsar S, Dayi SU, Kaya A, et al. Marfan syndrome with giant sinus of Valsalva aneurysm. Northern Clinics of Istanbul. 2015;1(3):174.

• Hayıroğlu Mİ, Keskin M, Keskin T, Kaya A, et al. Prognostic nutritional index in pulmonary embolism. Clinical and Applied Thrombosis/Hemostasis. 2018;24(4):633–639.

• Tatlisu MA, Sargin M, Kaya A, et al. Coronary artery size and demographics. Northern Clinics of Istanbul. 2018;5(1):20–24.

• Köroğlu B, Kaya A, Öz A, Keskin M, Nurkalem Z. ‘Ping-pong’ ball thrombus in the left atrium. Turkish Journal of Cardiology Archives. 2016;44(7):617.